Extended resuscitative endovascular balloon occlusion of the aorta (REBOA)-induced type 2 myocardial ischemia: a time-dependent penalty
Abstract
Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) increases cardiac-afterload and is used for patients in hemorrhagic shock. The cardiac tolerance of prolonged afterload augmentation in this context is unknown. The aim of this study is to quantify cardiac injury, if any, following 2, 3 and 4 hours of REBOA.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2019
- Source ID
- 10.1136/tsaco-2018-000194
Entities
People
- Hector Banchs
- Jonathan Morrison
- Melanie R. Hoehn
- Peter Hu
- Philip J. Wasicek
- Samuel M Galvagno
- Shiming Yang
- Thomas M. Scalea
- William A. Teeter
- William B. Gamble
Organizations
- United States Department of Defense